|
Volumn 76, Issue 9, 1995, Pages 1665-1670
|
Treatment of uveal melanoma metastatic to the liver. A review of the M. D. Anderson cancer center experience and prognostic factors
a a a a a a a a |
Author keywords
eye; melanoma; metastasis; neoplasm
|
Indexed keywords
AMSACRINE;
BCG VACCINE;
BLEOMYCIN;
CARMUSTINE;
CISPLATIN;
CORYNEBACTERIUM PARVUM EXTRACT;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DACTINOMYCIN;
HYDROXYUREA;
INTERFERON;
INTERLEUKIN 2;
PROCARBAZINE;
TAMOXIFEN;
VINBLASTINE;
VINCRISTINE;
VINDESINE;
ADULT;
AGED;
ARTICLE;
ARTIFICIAL EMBOLISM;
CANCER SURVIVAL;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
MULTIMODALITY CANCER THERAPY;
PRIORITY JOURNAL;
PROGNOSIS;
TREATMENT OUTCOME;
UVEA MELANOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
ALKALINE PHOSPHATASE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BILIRUBIN;
CHEMOEMBOLIZATION, THERAPEUTIC;
FEMALE;
HUMAN;
LACTATE DEHYDROGENASE;
LIFE TABLES;
LIVER NEOPLASMS;
LOGISTIC MODELS;
MALE;
MELANOMA;
MIDDLE AGE;
MULTIVARIATE ANALYSIS;
PROGNOSIS;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
UVEAL NEOPLASMS;
|
EID: 0028853939
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19951101)76:9<1665::AID-CNCR2820760925>3.0.CO;2-J Document Type: Article |
Times cited : (306)
|
References (19)
|